Polyamidoamine dendrimer and dextran conjugates: Preparation, characterization, and in vitro and in vivo evaluation

Chemical Papers

Volumn 64, Issue 5, 2010, Pages 592-601

  Shrivastava, Prabhat K ^a   Singh, Royana ^b   Shrivastava, Sushant K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

aceclofenac; biological evaluation; dextran; in vitro hydrolysis; PAMAM dendrimer

Indexed keywords

EID: 77956904551     PISSN: 03666352     EISSN: 13369075     Source Type: Journal    
DOI: 10.2478/s11696-010-0042-6     Document Type: Article

References (39)

1. Asthana, A., Chauhan, A. S., Diwan, P. V., & Jain, N. K. (2005). Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient. AAPS PharmSciTech, 6, E535-E542. DOI: 10. 1208/pt060367.
2. Burkhard, H., Thomas, R., Daniel, A., Ulrike, W., Robert, R., Stephan, R., & Kay, B. (2003). Aceclofenac spares cyclooxygenase-1 as a result of limited but sustained biotransformation to diclofenac. Journal of Clinical Pharmacy and Therapeutics, 74, 222-235. DOI: 10. 1016/S0009- 9236(03)00167-X.
3. Chauhan, A. S., Diwan, P. V., Jain, N. K., & Tomalia, D. A. (2009). Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. Biomacromolecules, 10, 1195-1202. DOI: 10. 1021/bm9000298.
4. Cheng, Y., Gao, Y., Rao, T., Li, Y., & Xu, T. (2007a). Dendrimer-based prodrugs: Design, synthesis, screening and biological evaluation. Combinatorial Chemistry & High Throughput Screening, 10, 336-349. DOI: 10. 2174/138620707781662808.
5. Cheng, Y., Man, N., Xu, T., Fu, R., Wang, X., Wang, X., & Wen, L. (2007b). Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. Journal of Pharmaceutical Sciences, 96, 595-602. DOI: 10. 1002/jps. 20745.
6. Cheng, Y., & Xu, T. (2008). The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of noncovalently or covalently attached drugs. European Journal of Medicinal Chemistry, 43, 2291-2297. DOI: 10. 1016/j. ejmech. 2007. 12. 021.
7. Cheng, Y., & Xu, T. (2005). Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. European Journal of Medicinal Chemistry, 40, 1188-1192. DOI: 10. 1016/j. ejmech. 2005. 06. 010.
8. Cheng, Y., Xu, T., & Fu, R. (2005). Polyamidoamine dendrimers used as solubility enhancers of ketoprofen. European Journal of Medicinal Chemistry, 40, 1390-1393. DOI: 10. 1016/j. ejmech. 2005. 08. 002.
9. Cheng, Y., Xu, Z., Ma, M., & Xu, T. (2008). Dendrimer as drug carrier: Application in different routes of drug administration. Journal of Pharmaceutical Sciences, 97, 123-143. DOI: 10. 1002/jps. 21079.
10. Davies, O. L., Raventós, J., & Walpole, A. L. (1946). A method for the evaluation of analgesic activity using rats. British Journal of Pharmacology, 1, 255-264.
11. Feldman, M., & McMahon, A. T. (2000). Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Annals of Internal Medicine, 132, 134-143.
12. 2 receptor antagonist. European Journal of Medicinal Chemistry, 44, 1155-1166. DOI: 10. 1016/j. ejmech. 2008. 06. 012.
13. Giannuzzo, M., Corrente, F., Feeney, M., Paoletti, L., Paolicelli, P., Tita, B., Vitali, F., & Casadei, M. A. (2008). pH-Sensitive hydrogels of dextran: Synthesis, characterization and in vivo studies. Journal of Drug Targeting, 16, 649-659. DOI: 10. 1080/10611860802201191.
14. Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K., & Isakson, P. C. (1999). Kinetic basis for selective inhibition of cyclo-oxygenases. Biochemical Journal, 339, 607-614. DOI: 10. 1042/0264-6021: 3390607.
15. Gurdag, S., Khandare, J., Stapels, S., Matherly, L. H., & Kannan, R. M. (2006). Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines. Bioconjugate Chemistry, 17, 275-283. DOI: 10. 1021/bc0501855.
16. Hoste, K., De Winne, K., & Schacht, E. (2004). Polymeric prodrugs. International Journal of Pharmaceutics, 277, 119-131. DOI: 10. 1016/j. ijpharm. 2003. 07. 016.
17. Jung, Y. J., Lee, J. S., Kim, H. H., Kim, Y. T., & Kim, Y. M. (1998). Synthesis and properties of dextran-5-aminosalicyclic acid ester as a potential colon-specific prodrug of 5-aminosalicyclic acid. Archives of Pharmacal Research, 21, 179-186.
18. Khandare, J., & Minko, T. (2006). Polymer-drug conjugates: Progress in polymeric prodrugs. Progress in Polymer Science, 31, 359-397. DOI: 10. 1016/j. progpolymsci. 2005. 09. 004.
19. Larsen, C. (1990). Dextran prodrugs-Physicochemical and chemical aspects in relation to in-vivo properties. Unpublished DSc. thesis. Copenhagen, Denmark: Villadsen & Christensen.
20. Larsen, C., Harboe, E., Johansen, M., & Olesen, H. P. (1989). Macromolecular prodrugs. XVI. Colon-targeted delivery-comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract. Pharmaceutical Research, 6, 995-999. DOI: 10. 1023/A: 1015914101233.
21. Lee, J. S., Jung, Y. J., Doh, M. J., & Kim, Y. M. (2001). Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid. Drug Development and Industrial Pharmacy, 27, 331-336. DOI: 10. 1081/DDC-100103732.
22. Man, N., Cheng, Y., Xu, T., Ding, Y., Wang, X., Li, Z., Chen, Z., Huang, G., Shi, Y., & Wen, L. (2006). Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies. European Journal of Medicinal Chemistry, 41, 670-674. DOI: 10. 1016/j. ejmech. 2006. 01. 001.
23. Mehvar, R. (2000). Dextrans for targeted and sustained delivery of therapeutic and imaging agents. Journal of Controlled Release, 69, 1-25. DOI: 10. 1016/S0168-3659(00)00302-3.
24. Mehvar, R. (1999). Simultaneous analysis of dextran-methylprednisolone succinate methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography. Journal of Pharmaceutical and Biomedical Analysis, 19, 785-792. DOI: 10. 1016/S0731-7085(98)00308-2.
25. Mehvar, R., Robinson, M. A., & Reynolds, J. M. (1994). Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats. Journal of Pharmaceutical Sciences, 83, 1495-1499. DOI: 10. 1002/jps. 2600831024.
26. Musmade, P., Subramanian, G., & Srinivasan, K. K. (2007). High-performance liquid chromatography and pharmacokinetics of aceclofenac in rats. Analytica Chimica Acta, 585, 103-109. DOI: 10. 1016/j. aca. 2006. 11. 080.
27. Najlah, M., Freeman, S., Attwood, D., & D'Emanuele, A. (2006). Synthesis, characterization and stability of dendrimer prodrugs. International Journal of Pharmaceutics, 308, 175-182. DOI: 10. 1016/j. ijpharm. 2005. 10. 033.
28. Rainsford, K. D. (1975). A synergistic interaction between aspirin, or other non-steroidal anti-inflammatory drugs, and stress which produces severe gastric mucosal damage in rats and pigs. Agents actions, 5, 553-558. DOI: 10. 1007/BF01972694.
29. Semble, E. L., Wu, W. C. (1987). Antiinflammatory drugs and gastric mucosal damage. Seminars in Arthritis and Rheumatism, 16, 271-286. DOI: 10. 1016/0049-0172(87)90005-9.
30. Shrivastava, S. K., Jain, D. K., & Trivedi, P. (2003a). Dextranspotential polymeric drug carriers for suprofen. Die Pharmazie, 58, 804-806.
31. Shrivastava, S. K., Jain, D. K., & Trivedi, P. (2003b). Dextranspotential polymeric drug carriers for flurbiprofen. Die Pharmazie, 58, 389-391.
32. Shrivastava, S. K., Shrivastava, P. K., Jain, D. K., Trivedi, P. (2009). Flurbiprofen- and suprofen-dextran conjugates: Synthesis, characterization and biological evaluation. Tropical Journal of Pharmaceutical Research, 8, 221-229.
33. Svenson, S., & Tomalia, D. A. (2005). Dendrimers in biomedical applications-reflections on the field. Advanced Drug Delivery Reviews, 57, 2106-2129. DOI: 10. 1016/j. addr. 2005. 09. 018.
34. Sweetman, S. C. (2007). Martindale: The complete drug reference (35th ed., pp. 11-12). London, UK: Pharmaceutical Press.
35. Tomalia, D. A., & Fréchet, J. M. (2005). Introduction to "dendrimers and dendritic polymers". Progress in Polymer Science, 30, 217-219. DOI: 10. 1016/j. progpolymsci. 2005. 03. 003.
36. Tomalia, D. A., Naylor, A. M., & Goddard, W. A. (1990). Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angewandte Chemie International Edition, 29, 138-175. DOI: 10. 1002/anie. 199001381.
37. Vane, J. (1994). Towards a better aspirin. Nature, 367, 215-216. DOI: 10. 1038/367215a0.
38. Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999). Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proceedings of the National Academy of Sciences, 96, 7563-7568.
39. Winter, C. A., Risley, E. A., & Nuss, G. W. (1962). Carrageenan induced oedema in the hind paw of the rat as an assay for anti-inflammatory drugs. Proceedings of the Society for Experimental Biology and Medicine, 111, 544-547.